Chemokine-mediated F-actin dynamics, polarity, and migration in B lymphocytes depend on WNK1 signaling
Science Signaling · 2024
DOI: 10.1126/scisignal.ade1119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2024. Verfasst von Il-Young Hwang und 5 weiteren Autor:innen. Beteiligte Einrichtung: B-cell Molecular Immunology Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of He…. Hauptthemen laut MEDLINE: B-Lymphocytes, Actins, WNK Lysine-Deficient Protein Kinase 1, Signal Transduction. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
Ligand-engaged chemokine receptors trigger nucleotide exchange in heterotrimeric Gα i proteins, which stimulates cytoskeletal reorganization and cell polarity changes. To better understand the signaling events responsible for these cellular changes, we focused on early changes in F-actin dynamics after engagement of the chemokine receptor CXCR5 in murine splenic B cells. Within 10 seconds of exposure to the CXCR5 ligand CXCL13, three-dimensional lamellar-like pseudopods and F-actin–rich ridges appeared. The transient F-actin increase depended on Gα i2/3 signaling, the PI3K/AKT pathway, ERK activation, phospholipase C activity, and Rac1/2 activation mediated by Dock2 (dedicator of cytokinesis 2). Immunoblot analyses identified the kinase WNK1 (with no lysine kinase 1) as a potential early AKT effector. Treating B cells with specific WNK inhibitors disrupted F-actin dynamics and impaired B cell polarity, motility, and chemotaxis. These changes were mimicked in a murine B cell line by CRISPR-Cas9 gene editing of Wnk1 , which also suggested that WNK1 contributed to B cell proliferation. Administration of a single dose of a WNK inhibitor transiently reduced B cell motility and polarity in the lymph nodes of live mice. These results indicate that WNK1 signaling maintains B cell responsiveness to CXCL13 and suggest that pharmacological inhibition of WNK1, which is involved in cancer progression and blood pressure regulation, may affect humoral immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- B-cell Molecular Immunology Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
ORCID-Profile: Il-Young Hwang, Ji Sung Kim, Chung Park, John H Kehrl
Förderung
- Intramural NIH HHS
Zitieren
APA
Hwang, I. Y., Kim, J. S., Harrison, K. A., Park, C., Shi, C. S., & Kehrl, J. H. (2024). Chemokine-mediated F-actin dynamics, polarity, and migration in B lymphocytes depend on WNK1 signaling. Science Signaling. https://doi.org/10.1126/scisignal.ade1119
Vancouver
Hwang IY, Kim JS, Harrison KA, Park C, Shi CS, Kehrl JH. Chemokine-mediated F-actin dynamics, polarity, and migration in B lymphocytes depend on WNK1 signaling. Science Signaling. 2024. doi:10.1126/scisignal.ade1119
BibTeX
@article{Hwang2024,
author = {Hwang, Il-Young and Kim, Ji Sung and Harrison, Kathleen A and Park, Chung and Shi, Chong Shan and Kehrl, John H},
title = {Chemokine-mediated F-actin dynamics, polarity, and migration in B lymphocytes depend on WNK1 signaling},
journal = {Science Signaling},
year = {2024},
doi = {10.1126/scisignal.ade1119}
}
EUVIMED